nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Chills—Paclitaxel—kidney cancer	0.000792	0.000792	CcSEcCtD
Remifentanil—Pruritus—Everolimus—kidney cancer	0.000791	0.000791	CcSEcCtD
Remifentanil—Anaphylactic shock—Vincristine—kidney cancer	0.00079	0.00079	CcSEcCtD
Remifentanil—Oedema—Vincristine—kidney cancer	0.00079	0.00079	CcSEcCtD
Remifentanil—Arrhythmia—Paclitaxel—kidney cancer	0.000789	0.000789	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000776	0.000776	CcSEcCtD
Remifentanil—Nervous system disorder—Vincristine—kidney cancer	0.000774	0.000775	CcSEcCtD
Remifentanil—Thrombocytopenia—Vincristine—kidney cancer	0.000773	0.000773	CcSEcCtD
Remifentanil—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000772	0.000773	CcSEcCtD
Remifentanil—Urticaria—Sorafenib—kidney cancer	0.000771	0.000771	CcSEcCtD
Remifentanil—Haematuria—Capecitabine—kidney cancer	0.000769	0.00077	CcSEcCtD
Remifentanil—Erythema—Paclitaxel—kidney cancer	0.000768	0.000769	CcSEcCtD
Remifentanil—Diarrhoea—Vinblastine—kidney cancer	0.000768	0.000768	CcSEcCtD
Remifentanil—Body temperature increased—Sorafenib—kidney cancer	0.000767	0.000767	CcSEcCtD
Remifentanil—Diarrhoea—Everolimus—kidney cancer	0.000765	0.000765	CcSEcCtD
Remifentanil—Hyperhidrosis—Vincristine—kidney cancer	0.000763	0.000764	CcSEcCtD
Remifentanil—Pruritus—Erlotinib—kidney cancer	0.000763	0.000763	CcSEcCtD
Remifentanil—Pain—Dactinomycin—kidney cancer	0.000756	0.000756	CcSEcCtD
Remifentanil—Oedema—Gemcitabine—kidney cancer	0.000749	0.000749	CcSEcCtD
Remifentanil—Anaphylactic shock—Gemcitabine—kidney cancer	0.000749	0.000749	CcSEcCtD
Remifentanil—Dizziness—Vinblastine—kidney cancer	0.000742	0.000742	CcSEcCtD
Remifentanil—Dizziness—Everolimus—kidney cancer	0.000739	0.000739	CcSEcCtD
Remifentanil—Body temperature increased—Sunitinib—kidney cancer	0.000738	0.000738	CcSEcCtD
Remifentanil—Diarrhoea—Erlotinib—kidney cancer	0.000738	0.000738	CcSEcCtD
Remifentanil—Hypotension—Vincristine—kidney cancer	0.000738	0.000738	CcSEcCtD
Remifentanil—Bradycardia—Capecitabine—kidney cancer	0.000737	0.000738	CcSEcCtD
Remifentanil—Nervous system disorder—Gemcitabine—kidney cancer	0.000735	0.000735	CcSEcCtD
Remifentanil—Thrombocytopenia—Gemcitabine—kidney cancer	0.000733	0.000734	CcSEcCtD
Remifentanil—Feeling abnormal—Dactinomycin—kidney cancer	0.000728	0.000729	CcSEcCtD
Remifentanil—Haemoglobin—Capecitabine—kidney cancer	0.000728	0.000728	CcSEcCtD
Remifentanil—Skin disorder—Gemcitabine—kidney cancer	0.000728	0.000728	CcSEcCtD
Remifentanil—Haemorrhage—Capecitabine—kidney cancer	0.000724	0.000725	CcSEcCtD
Remifentanil—Hyperhidrosis—Gemcitabine—kidney cancer	0.000724	0.000724	CcSEcCtD
Remifentanil—Tremor—Paclitaxel—kidney cancer	0.00072	0.00072	CcSEcCtD
Remifentanil—Pharyngitis—Capecitabine—kidney cancer	0.000719	0.000719	CcSEcCtD
Remifentanil—Hypersensitivity—Sorafenib—kidney cancer	0.000715	0.000715	CcSEcCtD
Remifentanil—Vomiting—Vinblastine—kidney cancer	0.000713	0.000714	CcSEcCtD
Remifentanil—Dizziness—Erlotinib—kidney cancer	0.000713	0.000713	CcSEcCtD
Remifentanil—Vomiting—Everolimus—kidney cancer	0.000711	0.000711	CcSEcCtD
Remifentanil—Anaemia—Paclitaxel—kidney cancer	0.00071	0.000711	CcSEcCtD
Remifentanil—Renal impairment—Doxorubicin—kidney cancer	0.000709	0.00071	CcSEcCtD
Remifentanil—Paraesthesia—Vincristine—kidney cancer	0.000709	0.000709	CcSEcCtD
Remifentanil—Agitation—Paclitaxel—kidney cancer	0.000706	0.000707	CcSEcCtD
Remifentanil—Rash—Everolimus—kidney cancer	0.000705	0.000705	CcSEcCtD
Remifentanil—Dermatitis—Everolimus—kidney cancer	0.000704	0.000704	CcSEcCtD
Remifentanil—Headache—Vinblastine—kidney cancer	0.000703	0.000703	CcSEcCtD
Remifentanil—Headache—Everolimus—kidney cancer	0.0007	0.000701	CcSEcCtD
Remifentanil—Hypotension—Gemcitabine—kidney cancer	0.0007	0.0007	CcSEcCtD
Remifentanil—Body temperature increased—Dactinomycin—kidney cancer	0.000699	0.000699	CcSEcCtD
Remifentanil—Visual impairment—Capecitabine—kidney cancer	0.000698	0.000698	CcSEcCtD
Remifentanil—Syncope—Paclitaxel—kidney cancer	0.000689	0.000689	CcSEcCtD
Remifentanil—Hypersensitivity—Sunitinib—kidney cancer	0.000688	0.000688	CcSEcCtD
Remifentanil—Pruritus—Sorafenib—kidney cancer	0.000686	0.000687	CcSEcCtD
Remifentanil—Vomiting—Erlotinib—kidney cancer	0.000686	0.000686	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Vincristine—kidney cancer	0.000682	0.000682	CcSEcCtD
Remifentanil—Rash—Erlotinib—kidney cancer	0.00068	0.00068	CcSEcCtD
Remifentanil—Dermatitis—Erlotinib—kidney cancer	0.000679	0.00068	CcSEcCtD
Remifentanil—Headache—Erlotinib—kidney cancer	0.000676	0.000676	CcSEcCtD
Remifentanil—Loss of consciousness—Paclitaxel—kidney cancer	0.000675	0.000676	CcSEcCtD
Remifentanil—Constipation—Vincristine—kidney cancer	0.000675	0.000676	CcSEcCtD
Remifentanil—Pain—Vincristine—kidney cancer	0.000675	0.000676	CcSEcCtD
Remifentanil—Paraesthesia—Gemcitabine—kidney cancer	0.000673	0.000673	CcSEcCtD
Remifentanil—Flushing—Capecitabine—kidney cancer	0.000672	0.000673	CcSEcCtD
Remifentanil—Cardiac disorder—Capecitabine—kidney cancer	0.000672	0.000673	CcSEcCtD
Remifentanil—Cough—Paclitaxel—kidney cancer	0.000671	0.000671	CcSEcCtD
Remifentanil—Dyspnoea—Gemcitabine—kidney cancer	0.000668	0.000668	CcSEcCtD
Remifentanil—Nausea—Vinblastine—kidney cancer	0.000666	0.000667	CcSEcCtD
Remifentanil—Somnolence—Gemcitabine—kidney cancer	0.000666	0.000666	CcSEcCtD
Remifentanil—Convulsion—Paclitaxel—kidney cancer	0.000666	0.000666	CcSEcCtD
Remifentanil—Nausea—Everolimus—kidney cancer	0.000664	0.000664	CcSEcCtD
Remifentanil—Diarrhoea—Sorafenib—kidney cancer	0.000664	0.000664	CcSEcCtD
Remifentanil—Hypertension—Paclitaxel—kidney cancer	0.000663	0.000664	CcSEcCtD
Remifentanil—Pruritus—Sunitinib—kidney cancer	0.00066	0.000661	CcSEcCtD
Remifentanil—Angiopathy—Capecitabine—kidney cancer	0.000657	0.000658	CcSEcCtD
Remifentanil—Immune system disorder—Capecitabine—kidney cancer	0.000654	0.000655	CcSEcCtD
Remifentanil—Mediastinal disorder—Capecitabine—kidney cancer	0.000653	0.000653	CcSEcCtD
Remifentanil—Anxiety—Paclitaxel—kidney cancer	0.000652	0.000652	CcSEcCtD
Remifentanil—Hypersensitivity—Dactinomycin—kidney cancer	0.000651	0.000651	CcSEcCtD
Remifentanil—Chills—Capecitabine—kidney cancer	0.00065	0.00065	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00065	0.00065	CcSEcCtD
Remifentanil—Arrhythmia—Capecitabine—kidney cancer	0.000647	0.000647	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000647	0.000647	CcSEcCtD
Remifentanil—Cardiac arrest—Doxorubicin—kidney cancer	0.000642	0.000642	CcSEcCtD
Remifentanil—Dizziness—Sorafenib—kidney cancer	0.000642	0.000642	CcSEcCtD
Remifentanil—Constipation—Gemcitabine—kidney cancer	0.000641	0.000641	CcSEcCtD
Remifentanil—Pain—Gemcitabine—kidney cancer	0.000641	0.000641	CcSEcCtD
Remifentanil—Nausea—Erlotinib—kidney cancer	0.000641	0.000641	CcSEcCtD
Remifentanil—Dry mouth—Paclitaxel—kidney cancer	0.00064	0.00064	CcSEcCtD
Remifentanil—Diarrhoea—Sunitinib—kidney cancer	0.000639	0.000639	CcSEcCtD
Remifentanil—Confusional state—Paclitaxel—kidney cancer	0.000632	0.000633	CcSEcCtD
Remifentanil—Erythema—Capecitabine—kidney cancer	0.000631	0.000631	CcSEcCtD
Remifentanil—Oedema—Paclitaxel—kidney cancer	0.000627	0.000627	CcSEcCtD
Remifentanil—Anaphylactic shock—Paclitaxel—kidney cancer	0.000627	0.000627	CcSEcCtD
Remifentanil—Body temperature increased—Vincristine—kidney cancer	0.000624	0.000624	CcSEcCtD
Remifentanil—Dizziness—Sunitinib—kidney cancer	0.000617	0.000618	CcSEcCtD
Remifentanil—Feeling abnormal—Gemcitabine—kidney cancer	0.000617	0.000618	CcSEcCtD
Remifentanil—Shock—Paclitaxel—kidney cancer	0.000617	0.000617	CcSEcCtD
Remifentanil—Vomiting—Sorafenib—kidney cancer	0.000617	0.000617	CcSEcCtD
Remifentanil—Nervous system disorder—Paclitaxel—kidney cancer	0.000615	0.000615	CcSEcCtD
Remifentanil—Hypokalaemia—Doxorubicin—kidney cancer	0.000614	0.000615	CcSEcCtD
Remifentanil—Thrombocytopenia—Paclitaxel—kidney cancer	0.000614	0.000614	CcSEcCtD
Remifentanil—Tachycardia—Paclitaxel—kidney cancer	0.000612	0.000612	CcSEcCtD
Remifentanil—Rash—Sorafenib—kidney cancer	0.000612	0.000612	CcSEcCtD
Remifentanil—Dermatitis—Sorafenib—kidney cancer	0.000611	0.000611	CcSEcCtD
Remifentanil—Skin disorder—Paclitaxel—kidney cancer	0.000609	0.000609	CcSEcCtD
Remifentanil—Headache—Sorafenib—kidney cancer	0.000608	0.000608	CcSEcCtD
Remifentanil—Hyperhidrosis—Paclitaxel—kidney cancer	0.000606	0.000607	CcSEcCtD
Remifentanil—Diarrhoea—Dactinomycin—kidney cancer	0.000605	0.000605	CcSEcCtD
Remifentanil—Nasopharyngitis—Doxorubicin—kidney cancer	0.000604	0.000604	CcSEcCtD
Remifentanil—Vomiting—Sunitinib—kidney cancer	0.000594	0.000594	CcSEcCtD
Remifentanil—Body temperature increased—Gemcitabine—kidney cancer	0.000592	0.000592	CcSEcCtD
Remifentanil—Tremor—Capecitabine—kidney cancer	0.000591	0.000591	CcSEcCtD
Remifentanil—Rash—Sunitinib—kidney cancer	0.000589	0.000589	CcSEcCtD
Remifentanil—Dermatitis—Sunitinib—kidney cancer	0.000588	0.000588	CcSEcCtD
Remifentanil—Hypotension—Paclitaxel—kidney cancer	0.000586	0.000586	CcSEcCtD
Remifentanil—Headache—Sunitinib—kidney cancer	0.000585	0.000585	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—kidney cancer	0.000583	0.000584	CcSEcCtD
Remifentanil—Anaemia—Capecitabine—kidney cancer	0.000583	0.000583	CcSEcCtD
Remifentanil—Hypersensitivity—Vincristine—kidney cancer	0.000582	0.000582	CcSEcCtD
Remifentanil—Nausea—Sorafenib—kidney cancer	0.000576	0.000577	CcSEcCtD
Remifentanil—Syncope—Capecitabine—kidney cancer	0.000566	0.000566	CcSEcCtD
Remifentanil—Paraesthesia—Paclitaxel—kidney cancer	0.000563	0.000563	CcSEcCtD
Remifentanil—Vomiting—Dactinomycin—kidney cancer	0.000562	0.000562	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—kidney cancer	0.000561	0.000561	CcSEcCtD
Remifentanil—Dyspnoea—Paclitaxel—kidney cancer	0.000559	0.000559	CcSEcCtD
Remifentanil—Somnolence—Paclitaxel—kidney cancer	0.000558	0.000558	CcSEcCtD
Remifentanil—Rash—Dactinomycin—kidney cancer	0.000557	0.000557	CcSEcCtD
Remifentanil—Nausea—Sunitinib—kidney cancer	0.000554	0.000555	CcSEcCtD
Remifentanil—Loss of consciousness—Capecitabine—kidney cancer	0.000554	0.000555	CcSEcCtD
Remifentanil—Dyspepsia—Paclitaxel—kidney cancer	0.000552	0.000552	CcSEcCtD
Remifentanil—Cough—Capecitabine—kidney cancer	0.00055	0.000551	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—kidney cancer	0.000546	0.000546	CcSEcCtD
Remifentanil—Hypertension—Capecitabine—kidney cancer	0.000544	0.000545	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000541	0.000542	CcSEcCtD
Remifentanil—Diarrhoea—Vincristine—kidney cancer	0.00054	0.000541	CcSEcCtD
Remifentanil—Pain—Paclitaxel—kidney cancer	0.000536	0.000537	CcSEcCtD
Remifentanil—Constipation—Paclitaxel—kidney cancer	0.000536	0.000537	CcSEcCtD
Remifentanil—Anxiety—Capecitabine—kidney cancer	0.000535	0.000535	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000533	0.000533	CcSEcCtD
Remifentanil—Pruritus—Gemcitabine—kidney cancer	0.00053	0.00053	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—kidney cancer	0.000526	0.000527	CcSEcCtD
Remifentanil—Dry mouth—Capecitabine—kidney cancer	0.000525	0.000525	CcSEcCtD
Remifentanil—Nausea—Dactinomycin—kidney cancer	0.000525	0.000525	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—kidney cancer	0.000523	0.000523	CcSEcCtD
Remifentanil—Dizziness—Vincristine—kidney cancer	0.000522	0.000522	CcSEcCtD
Remifentanil—Confusional state—Capecitabine—kidney cancer	0.000519	0.000519	CcSEcCtD
Remifentanil—Feeling abnormal—Paclitaxel—kidney cancer	0.000517	0.000517	CcSEcCtD
Remifentanil—Oedema—Capecitabine—kidney cancer	0.000515	0.000515	CcSEcCtD
Remifentanil—Diarrhoea—Gemcitabine—kidney cancer	0.000513	0.000513	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—kidney cancer	0.000511	0.000512	CcSEcCtD
Remifentanil—Shock—Capecitabine—kidney cancer	0.000506	0.000507	CcSEcCtD
Remifentanil—Nervous system disorder—Capecitabine—kidney cancer	0.000505	0.000505	CcSEcCtD
Remifentanil—Thrombocytopenia—Capecitabine—kidney cancer	0.000504	0.000504	CcSEcCtD
Remifentanil—Tachycardia—Capecitabine—kidney cancer	0.000502	0.000503	CcSEcCtD
Remifentanil—Vomiting—Vincristine—kidney cancer	0.000502	0.000502	CcSEcCtD
Remifentanil—Skin disorder—Capecitabine—kidney cancer	0.0005	0.0005	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—kidney cancer	0.000499	0.000499	CcSEcCtD
Remifentanil—Urticaria—Paclitaxel—kidney cancer	0.000498	0.000498	CcSEcCtD
Remifentanil—Rash—Vincristine—kidney cancer	0.000498	0.000498	CcSEcCtD
Remifentanil—Hyperhidrosis—Capecitabine—kidney cancer	0.000498	0.000498	CcSEcCtD
Remifentanil—Dermatitis—Vincristine—kidney cancer	0.000497	0.000498	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—kidney cancer	0.000496	0.000496	CcSEcCtD
Remifentanil—Body temperature increased—Paclitaxel—kidney cancer	0.000496	0.000496	CcSEcCtD
Remifentanil—Headache—Vincristine—kidney cancer	0.000495	0.000495	CcSEcCtD
Remifentanil—Hypotension—Capecitabine—kidney cancer	0.000481	0.000481	CcSEcCtD
Remifentanil—Vomiting—Gemcitabine—kidney cancer	0.000476	0.000476	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—kidney cancer	0.000475	0.000476	CcSEcCtD
Remifentanil—Rash—Gemcitabine—kidney cancer	0.000472	0.000473	CcSEcCtD
Remifentanil—Dermatitis—Gemcitabine—kidney cancer	0.000472	0.000472	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—kidney cancer	0.000469	0.00047	CcSEcCtD
Remifentanil—Headache—Gemcitabine—kidney cancer	0.000469	0.000469	CcSEcCtD
Remifentanil—Nausea—Vincristine—kidney cancer	0.000469	0.000469	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—kidney cancer	0.000467	0.000467	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—kidney cancer	0.000463	0.000464	CcSEcCtD
Remifentanil—Paraesthesia—Capecitabine—kidney cancer	0.000462	0.000462	CcSEcCtD
Remifentanil—Hypersensitivity—Paclitaxel—kidney cancer	0.000462	0.000462	CcSEcCtD
Remifentanil—Dyspnoea—Capecitabine—kidney cancer	0.000459	0.000459	CcSEcCtD
Remifentanil—Dyspepsia—Capecitabine—kidney cancer	0.000453	0.000453	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—kidney cancer	0.00045	0.00045	CcSEcCtD
Remifentanil—Nausea—Gemcitabine—kidney cancer	0.000445	0.000445	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000444	0.000445	CcSEcCtD
Remifentanil—Pruritus—Paclitaxel—kidney cancer	0.000444	0.000444	CcSEcCtD
Remifentanil—Constipation—Capecitabine—kidney cancer	0.00044	0.00044	CcSEcCtD
Remifentanil—Pain—Capecitabine—kidney cancer	0.00044	0.00044	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—kidney cancer	0.000433	0.000434	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—kidney cancer	0.000433	0.000434	CcSEcCtD
Remifentanil—Diarrhoea—Paclitaxel—kidney cancer	0.000429	0.000429	CcSEcCtD
Remifentanil—Feeling abnormal—Capecitabine—kidney cancer	0.000424	0.000424	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—kidney cancer	0.000424	0.000424	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—kidney cancer	0.000422	0.000422	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—kidney cancer	0.000421	0.000421	CcSEcCtD
Remifentanil—Chills—Doxorubicin—kidney cancer	0.000419	0.000419	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—kidney cancer	0.000417	0.000417	CcSEcCtD
Remifentanil—Dizziness—Paclitaxel—kidney cancer	0.000415	0.000415	CcSEcCtD
Remifentanil—Urticaria—Capecitabine—kidney cancer	0.000409	0.000409	CcSEcCtD
Remifentanil—Body temperature increased—Capecitabine—kidney cancer	0.000407	0.000407	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—kidney cancer	0.000406	0.000407	CcSEcCtD
Remifentanil—Vomiting—Paclitaxel—kidney cancer	0.000399	0.000399	CcSEcCtD
Remifentanil—Rash—Paclitaxel—kidney cancer	0.000395	0.000396	CcSEcCtD
Remifentanil—Dermatitis—Paclitaxel—kidney cancer	0.000395	0.000395	CcSEcCtD
Remifentanil—Headache—Paclitaxel—kidney cancer	0.000393	0.000393	CcSEcCtD
Remifentanil—Hypersensitivity—Capecitabine—kidney cancer	0.000379	0.000379	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—kidney cancer	0.000376	0.000376	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—kidney cancer	0.000374	0.000374	CcSEcCtD
Remifentanil—Nausea—Paclitaxel—kidney cancer	0.000373	0.000373	CcSEcCtD
Remifentanil—Alfentanil—ABCB1—kidney cancer	0.000365	0.732	CrCbGaD
Remifentanil—Syncope—Doxorubicin—kidney cancer	0.000365	0.000365	CcSEcCtD
Remifentanil—Pruritus—Capecitabine—kidney cancer	0.000364	0.000364	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—kidney cancer	0.000357	0.000357	CcSEcCtD
Remifentanil—Cough—Doxorubicin—kidney cancer	0.000355	0.000355	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—kidney cancer	0.000352	0.000352	CcSEcCtD
Remifentanil—Diarrhoea—Capecitabine—kidney cancer	0.000352	0.000352	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—kidney cancer	0.000351	0.000351	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—kidney cancer	0.000345	0.000345	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000344	0.000344	CcSEcCtD
Remifentanil—Dizziness—Capecitabine—kidney cancer	0.00034	0.00034	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—kidney cancer	0.000338	0.000339	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—kidney cancer	0.000335	0.000335	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—kidney cancer	0.000332	0.000332	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—kidney cancer	0.000332	0.000332	CcSEcCtD
Remifentanil—Vomiting—Capecitabine—kidney cancer	0.000327	0.000327	CcSEcCtD
Remifentanil—Shock—Doxorubicin—kidney cancer	0.000326	0.000327	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—kidney cancer	0.000325	0.000325	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—kidney cancer	0.000325	0.000325	CcSEcCtD
Remifentanil—Rash—Capecitabine—kidney cancer	0.000324	0.000325	CcSEcCtD
Remifentanil—Dermatitis—Capecitabine—kidney cancer	0.000324	0.000324	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—kidney cancer	0.000324	0.000324	CcSEcCtD
Remifentanil—Headache—Capecitabine—kidney cancer	0.000322	0.000323	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—kidney cancer	0.000322	0.000322	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—kidney cancer	0.000321	0.000321	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—kidney cancer	0.00031	0.00031	CcSEcCtD
Remifentanil—Nausea—Capecitabine—kidney cancer	0.000306	0.000306	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—kidney cancer	0.000298	0.000298	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—kidney cancer	0.000296	0.000296	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—kidney cancer	0.000295	0.000295	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—kidney cancer	0.000292	0.000292	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000286	0.000287	CcSEcCtD
Remifentanil—Pain—Doxorubicin—kidney cancer	0.000284	0.000284	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—kidney cancer	0.000284	0.000284	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—kidney cancer	0.000273	0.000274	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—kidney cancer	0.000264	0.000264	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—kidney cancer	0.000262	0.000262	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—kidney cancer	0.000244	0.000245	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—kidney cancer	0.000235	0.000235	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—kidney cancer	0.000227	0.000227	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—kidney cancer	0.000211	0.000211	CcSEcCtD
Remifentanil—Rash—Doxorubicin—kidney cancer	0.000209	0.000209	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—kidney cancer	0.000209	0.000209	CcSEcCtD
Remifentanil—Headache—Doxorubicin—kidney cancer	0.000208	0.000208	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—kidney cancer	0.000197	0.000197	CcSEcCtD
Remifentanil—Fentanyl—ABCB1—kidney cancer	0.000134	0.268	CrCbGaD
